journal article·2026-03

Engineered Bacterial Outer Membrane Vesicles Remodel Tumor Microenvironment for Enhanced Photodynamic Immunotherapy

Chaofan Nie, Peiren Wang, Junru Wang, Zijian Zhou, Liu Yang, Xia Zhang, Tao Feng, Peng Li

Advanced Healthcare Materials· Volume 15· Issue 11
Publisher page

Abstract

ABSTRACT Tumor immunotherapy harnesses the immune system to recognize and eliminate tumor cells, offering notable advantages of precise targeting and sustained antitumor responses. However, the immunosuppressive tumor microenvironment (TME) often limits the monotherapy effectiveness, resulting in immune evasion and treatment resistance. Moreover, various therapeutic agents capable of modulating the TME suffer from poor aqueous solubility and severe systemic toxicity. In this study, an engineered nanotherapeutic platform, PN@OMVs, is prepared by co‐encapsulating the photosensitizer pheophorbide a (PPa) and the indoleamine 2,3‐dioxygenase 1 (IDO1) inhibitor NLG919 within Escherichia coli BL21‐derived outer membrane vesicles (OMVs). In a murine bilateral subcutaneous CT26 colon cancer model, PN@OMVs markedly enhanced systemic antitumor immunity through the synergistic effects of OMV‐incorporated pathogen‐associated molecular patterns (PAMPs) and photodynamic therapy‐induced immunogenic cell death, increasing dendritic cell maturation from 2.77% to 19.84%. Meanwhile, PN@OMVs significantly inhibited IDO1 activity, disrupted the tryptophan‐kynurenine metabolic pathway, and diminished regulatory T cell infiltration within tumor tissues, thereby reversing the immunosuppressive TME. Most importantly, a single administration combined with light irradiation could achieve tumor inhibition rates of 92.3% in primary tumors and 83.1% in distant tumors, without observable systemic toxicity. This study presents a promising paradigm of developing engineered OMVs to effectively remodel the TME for enhanced immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Research and Treatments · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Flexible Electronics (LoFE) Xi'an Institute of Flexible Electronics and Xi'an Institute of Biomedical Materials and Engineering Northwestern Polytechnical University Xi'an China

Queen Mary University of London Engineering School Northwestern Polytechnical University Xi'an China

Henan Institute of Flexible Electronics (HIFE) and School of Flexible Electronics Henan University Zhengzhou China

Funding

National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.1021/jacs.3c1400510.1021/jacs.3c14005 ↗
2. 10.1038/s41467‐024‐53392‐110.1038/s41467‐024‐53392‐1 ↗
3. 10.1002/adma.20241805310.1002/adma.202418053 ↗
4. 10.1038/s41587‐025‐02597‐w10.1038/s41587‐025‐02597‐w ↗
5. 10.1038/s41591‐025‐03636‐410.1038/s41591‐025‐03636‐4 ↗
6. 10.1002/anie.20250377610.1002/anie.202503776 ↗
7. 10.1038/s41467‐025‐56691‐310.1038/s41467‐025‐56691‐3 ↗
8. 10.1038/s41528‐024‐00345‐910.1038/s41528‐024‐00345‐9 ↗
9. 10.1038/s41586‐022‐05202‐110.1038/s41586‐022‐05202‐1 ↗
10. 10.1016/j.cej.2024.15456710.1016/j.cej.2024.154567 ↗
11. 10.1016/j.biomaterials.2025.12348810.1016/j.biomaterials.2025.123488 ↗
12. 10.1002/adma.20240547510.1002/adma.202405475 ↗
13. 10.1002/adma.20230726310.1002/adma.202307263 ↗
14. 10.1038/s41467‐025‐55904‐z10.1038/s41467‐025‐55904‐z ↗
15. 10.1021/acsnano.4c0292110.1021/acsnano.4c02921 ↗
16. 10.1002/adhm.20240506110.1002/adhm.202405061 ↗
17. 10.1002/adma.20231309710.1002/adma.202313097 ↗
18. 10.1021/jacs.4c1163610.1021/jacs.4c11636 ↗
19. 10.1002/adma.20250195310.1002/adma.202501953 ↗
20. 10.1021/acsnano.4c0526610.1021/acsnano.4c05266 ↗
21. 10.1038/s41392‐025‐02186‐y10.1038/s41392‐025‐02186‐y ↗
22. 10.1038/s41565‐024‐01757‐410.1038/s41565‐024‐01757‐4 ↗
23. 10.1016/j.jconrel.2024.08.03610.1016/j.jconrel.2024.08.036 ↗
24. 10.1002/adma.20241307810.1002/adma.202413078 ↗
25. 10.1007/s12274‐021‐3949‐z10.1007/s12274‐021‐3949‐z ↗
26. 10.1021/acsnano.5c0254110.1021/acsnano.5c02541 ↗
27. 10.1038/s41467‐023‐38679‐z10.1038/s41467‐023‐38679‐z ↗
28. 10.1021/acsnano.3c0264610.1021/acsnano.3c02646 ↗
29. 10.1016/j.cej.2025.16267810.1016/j.cej.2025.162678 ↗
30. 10.1038/s41467‐024‐51364‐z10.1038/s41467‐024‐51364‐z ↗
31. 10.1021/acsnano.3c0036310.1021/acsnano.3c00363 ↗
32. 10.1038/ncomms1051510.1038/ncomms10515 ↗
33. 10.1038/s41564-024-01823-610.1038/s41564-024-01823-6 ↗
34. 10.1016/j.biomaterials.2025.12377010.1016/j.biomaterials.2025.123770 ↗
35. 10.1021/jacs.3c0947210.1021/jacs.3c09472 ↗
36. 10.1002/adma.20241339210.1002/adma.202413392 ↗
37. 10.1021/jacs.5c0277410.1021/jacs.5c02774 ↗
38. 10.1186/s12951‐024‐02786‐w10.1186/s12951‐024‐02786‐w ↗
39. 10.1021/acsnano.4c0736410.1021/acsnano.4c07364 ↗
40. 10.1038/s41467‐023‐37369‐010.1038/s41467‐023‐37369‐0 ↗
41. 10.1002/advs.20240004910.1002/advs.202400049 ↗
42. 10.1002/adma.20230615810.1002/adma.202306158 ↗
43. 10.1016/j.mtbio.2025.10225110.1016/j.mtbio.2025.102251 ↗
44. 10.1002/advs.20250500010.1002/advs.202505000 ↗
45. 10.1021/acsnano.4c1141210.1021/acsnano.4c11412 ↗
46. 10.1016/j.biomaterials.2024.12303710.1016/j.biomaterials.2024.123037 ↗
47. 10.1016/j.matt.2024.09.01210.1016/j.matt.2024.09.012 ↗
48. 10.1002/advs.20250415510.1002/advs.202504155 ↗
49. 10.1021/acsnano.3c0571410.1021/acsnano.3c05714 ↗